Session

Friday
March 22
10:30 - 11:30
Auditorium
HPV and biomarker-led studies
Lisa Licitra, Italy;
Steven Frank, USA
0075
Proffered papers
10:30 - 10:40
Refining cN classification for HPV-positive oropharyngeal carcinoma: a multi-center study
Shao Hui Huang, Canada
10:40 - 10:50
Differential functional outcomes following transoral surgery for oropharyngeal carcinoma – laser versus robot
James O'Hara, United Kingdom
10:50 - 11:00
Longitudinal assessment of plasma EBV-DNA in non-endemic EBV-related nasopharyngeal cancers (NPC)
Salvatore Alfieri, Italy
11:00 - 11:10
Development of a Normal Tissue Complication Probability Model for Dysphagia in PATHOS trial patients
Emma Higgins, United Kingdom
11:10 - 11:20
Long-Term Results of Induction Chemotherapy Followed by 50 Gy Radiation Therapy Alone for Low-Risk HPV-Positive Oropharynx Cancer
Aditya Juloori, USA
11:20 - 11:30
Using quantitative diffusion-weighted MRI to predict treatment outcome and Human Papillomavirus status in patients with oropharyngeal squamous cell carcinoma
Heleen Bollen, Belgium